CatalystPit

ZNTLZentalis Pharmaceuticals, Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $2.77 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$198.53M
CountryUSA
RECENT INSIDER TRADES
  • 2026-10-01 · Bruns Ingmar (Chief Medical Officer) · OTHER
  • 2026-08-19 · WALTERS GROUP (10% Owner) · BUY
  • 2026-06-18 · Skvarka Jan (Director) · OTHER
  • 2026-06-18 · Walker Luke Nathaniel (Director) · OTHER
  • 2026-06-18 · Kariuki Enoch (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders127
Shares held59,155,628
Value$245.99M
Percent of shares outstanding82.54%
As of quarter end2026-06-30
RECENT NEWS
  • ZNTL: Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • Zentalis Pharmaceuticals presents at Morgan Stanley healthcare conference
  • ZNTL: Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Zentalis Pharmaceuticals, Inc. (ZNTL) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit